In the present study, H19 was observed to be up-regulated in NAFLD animal model and cellular model and knockdown H19 can inhibit lipid accumulation and TG secretion in FFA-induced HCC cells, which is consistent with previous research, indicating that H19 plays regulatory roles in NAFLD progression. Here, H19 is linked to metabolic dysfunction-associated steatotic liver disease.